Avalo Therapeutics
AVTX
AVTX
21 hedge funds and large institutions have $9.62M invested in Avalo Therapeutics in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$6.72M | |
| 2 | +$764K | |
| 3 | +$499K | |
| 4 |
AAA
Affinity Asset Advisors
New York
|
+$436K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$129K |
Top Sellers
| 1 | -$131K | |
| 2 | -$54.6K | |
| 3 | -$51.5K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$35.7K |
| 5 |
BlackRock
New York
|
-$22.4K |